Clinical Trial Update: Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficiency of FibroScan liver stiffness measurements and dedicated probes in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Fibrosis

Drugs mentioned

• FibroScan

Snippet

Sponsor: Echosens | Conditions: Liver Fibrosis, Cirrhosis | NA | Status: COMPLETED